Nicole J Ullrich
Overview
Explore the profile of Nicole J Ullrich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
2659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yun A, Griffin A, Kim H, Ullrich N, Licameli G
Pediatr Neurol
. 2024 Aug;
159:35-40.
PMID: 39111256
Background: Hearing loss has not been thoroughly investigated as a comorbidity in larger cohorts with neurofibromatosis type 1 (NF1). Methods: Available audiometric data were reviewed from patients with NF1 seen...
2.
Anastasopoulou S, Swann G, Andres-Jensen L, Attarbaschi A, Barzilai-Birenboim S, Erdelyi D, et al.
Br J Haematol
. 2024 Jun;
205(4):1450-1459.
PMID: 38924051
Steroids are a mainstay in the treatment of acute lymphoblastic leukaemia (ALL) in children and adolescents; however, their use can cause clinically significant steroid-related neuropsychiatric symptoms (SRNS). As current knowledge...
3.
Lunde C, Dudek M, Talbert C, Sieberg C, Silva K, Papadelis C, et al.
Appl Neuropsychol Child
. 2024 Apr;
:1-11.
PMID: 38604218
This pilot study investigated the long-term impact of a surgery-only treatment (no exposure to other treatments, such as chemotherapy and radiation) for pediatric cerebellar low-grade gliomas on executive function, anxiety,...
4.
Peters K, Templer J, Gerstner E, Wychowski T, Storstein A, Dixit K, et al.
Neurology
. 2024 Jan;
102(4):e209163.
PMID: 38290092
Patients with brain tumors will experience seizures during their disease course. While providers can use antiseizure medications to control these events, patients with brain tumors can experience side effects, ranging...
5.
Estrela T, Truong S, Garcia A, He J, Ying G, Devakandan K, et al.
J Neuroophthalmol
. 2024 Jan;
44(1):5-9.
PMID: 38252486
Background: Choroidal abnormalities (CAs) visualized on near-infrared reflectance (NIR) imaging are a new diagnostic criterion for neurofibromatosis type 1 (NF1), but the association between the presence of CAs and visual...
6.
Vuotto S, Wang M, Okcu M, Bowers D, Ullrich N, Ness K, et al.
Ann Clin Transl Neurol
. 2023 Nov;
11(2):291-301.
PMID: 38013658
Objective: To examine associations between neurologic late effects and attainment of independence in adult survivors of childhood cancer treated with central nervous system (CNS)-directed therapies. Methods: A total of 7881...
7.
Lehman L, Ullrich N
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894478
Cerebrovascular abnormalities are a severe and often underrecognized complication of childhood neurofibromatosis type 1 (NF1). There are no prospective studies of cerebral vasculopathy in NF1; thus, the estimated frequency of...
8.
Gross A, Plotkin S, Watts N, Fisher M, Klesse L, Lessing A, et al.
Clin Trials
. 2023 Sep;
21(1):29-39.
PMID: 37772407
Neurofibromatosis type 1 is a genetic syndrome characterized by a wide variety of tumor and non-tumor manifestations. Bone-related issues, such as scoliosis, tibial dysplasia, and low bone mineral density, are...
9.
Esbenshade A, Sung L, Brackett J, Dupuis L, Fisher B, Grimes A, et al.
Pediatr Blood Cancer
. 2023 Jul;
70 Suppl 6:e30568.
PMID: 37430431
The objective of the Cancer Control and Supportive Care (CCL) Committee in the Children's Oncology Group (COG) is to reduce the overall morbidity and mortality of therapy-related toxicities in children,...
10.
Shaikh R, Weil B, Weldon C, Chen N, London W, Krush M, et al.
Cancer Med
. 2023 Jun;
12(12):13300-13308.
PMID: 37264747
Background: Pediatric interventional oncology (PIO) is a growing field intended to provide additional or alternative treatment options for pediatric patients with benign or malignant tumors. Large series of patients treated...